Mölnlycke joins AstraZeneca BioVentureHub


Photographer: Jenny Johansson

AstraZeneca's CEO Sweden, Jan-Olof Jacke, signs the agreement with Mölnlycke's Executive Vice President for R&D, Barry McBride on 1 June 2017

Low resolution

Medium resolution

Original resolution

About Us

Mölnlycke Health Care is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. Mölnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries around the world. Founded in 1849, Mölnlycke is owned by Investor AB and headquartered in Sweden. www.molnlycke.com

Subscribe